Suppr超能文献

经肛门微创手术 内镜下黏膜切除术治疗直肠良性肿瘤和直肠类癌:一项回顾性分析。

Transanal minimally invasive surgery endoscopic mucosal resection for rectal benign tumors and rectal carcinoids: A retrospective analysis.

作者信息

Shen Jia-Men, Zhao Jia-Ying, Ye Tao, Gong Li-Feng, Wang Hui-Peng, Chen Wen-Jie, Cai Yuan-Kun

机构信息

Department of General Surgery, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.

出版信息

World J Clin Cases. 2020 Oct 6;8(19):4311-4319. doi: 10.12998/wjcc.v8.i19.4311.

Abstract

BACKGROUND

Transanal minimally invasive surgery (TAMIS) is a good choice for resection of rectal neoplasms. Endoscopic mucosal resection (EMR) is also widely used in the treatment of benign rectal tumors such as rectal polyps and rectal adenomas. However, no studies have compared the outcome of TAMIS and EMR.

AIM

To compare the short-term outcomes after TAMIS and EMR for rectal carcinoid and benign tumors (including rectal polyps and adenomas).

METHODS

From January 2014 to January 2019, 44 patients who received TAMIS and 53 patients who received EMR at The Fifth People's Hospital of Shanghai were selected. Primary outcomes (surgical-related) were operating time, blood loss, length of postoperative hospital stay, rate of resection margin involvement and lesion fragmentation rate. The secondary outcomes were complications such as hemorrhage, urinary retention, postoperative infection and reoperation.

RESULTS

No significant differences were observed in terms of blood loss (12.48 ± 8.00 mL for TAMIS 11.45 ± 7.82 mL for EMR, = 0.527) and length of postoperative hospital stay (3.50 ± 1.87 d for TAMIS 2.72 ± 1.98 d for EMR, = 0.065) between the two groups. Operating time was significantly shorter for EMR compared with TAMIS (21.19 ± 9.49 min 49.95 ± 15.28 min, = 0.001). The lesion fragmentation rate in the EMR group was 22.6% (12/53) and was significantly higher than that (0%, 0/44) in the TAMIS group ( = 0.001). TAMIS was associated with a higher urinary retention rate (13.6%, 6/44 1.9%, 1/53 = 0.026) and lower hemorrhage rate (0%, 0/44 18.9%, 10/53 = 0.002). A significantly higher reoperation rate was observed in the EMR group (9.4%, 5/53 0%, 0/44 = 0.036).

CONCLUSION

Compared with EMR, TAMIS can remove lesions more completely with effective hemostasis and lower postoperative hemorrhage and reoperation rates. TAMIS is a better choice for the treatment of rectal carcinoids.

摘要

背景

经肛门微创手术(TAMIS)是直肠肿瘤切除的一个不错选择。内镜黏膜切除术(EMR)也广泛应用于直肠息肉和直肠腺瘤等良性直肠肿瘤的治疗。然而,尚无研究比较TAMIS和EMR的疗效。

目的

比较TAMIS和EMR治疗直肠类癌及良性肿瘤(包括直肠息肉和腺瘤)后的短期疗效。

方法

选取2014年1月至2019年1月在上海市第五人民医院接受TAMIS治疗的44例患者和接受EMR治疗的53例患者。主要结局指标(与手术相关)为手术时间、出血量、术后住院时间、切缘受累率和病变破碎率。次要结局指标为出血、尿潴留、术后感染和再次手术等并发症。

结果

两组在出血量(TAMIS组为12.48±8.00 mL,EMR组为11.45±7.82 mL,P = 0.527)和术后住院时间(TAMIS组为3.50±1.87 d,EMR组为2.72±1.98 d,P = 0.065)方面未观察到显著差异。与TAMIS相比,EMR的手术时间显著更短(21.19±9.49分钟 vs 49.95±15.28分钟,P = 0.001)。EMR组的病变破碎率为22.6%(12/53),显著高于TAMIS组(0%,0/44)(P = 0.001)。TAMIS的尿潴留率较高(13.6%,6/44 vs 1.9%,1/53,P = 0.026),出血率较低(0%,0/44 vs 18.9%,10/53,P = 0.002)。EMR组的再次手术率显著更高(9.4%,5/53 vs 0%,0/44,P = 0.036)。

结论

与EMR相比,TAMIS能更彻底地切除病变,有效止血,降低术后出血和再次手术率。TAMIS是治疗直肠类癌的更好选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0850/7559669/b852bbf985bd/WJCC-8-4311-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验